Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ANTHRACITE, R. F.
Right arrow Articles by KNAPP, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ANTHRACITE, R. F.
Right arrow Articles by KNAPP, P. H.

Psychosomatic Medicine 33:481-490 (1971)
© 1971 American Psychosomatic Society

Alpha-Adrenergic Receptors in the Human Lung

RAYMOND F. ANTHRACITE BA1, LOUIS VACHON MD1, and PETER H. KNAPP MD1

1 Division of Psychiatry, Boston University Medical School Boston, Mass.

Louis Vachon, MD, 720 Harrison Ave, Suite 605, Boston, Mass 02118

The whole-body plethysmograph was used to study airway conductance (Gaw/Vgt) in humans after adrenergic agents, nebulized in a propylene glycol and water vehicle, were inhaled. Ten young males free of pulmonary or other disease were given the vehicle alone as well as the {alpha} stimulant, methoxamine. Gaw/Vgt increased slightly after the vehicle was administered. However, in all 10 subjects, a decrease was noted after they had received methoxamine alone. The {alpha} blocker, phentolamine, was given to 7 additional subjects; it produced a slight increase in Gaw/Vgt. When blocker and {alpha} stimulant were given together, the previous decrease seen with methoxamine alone was abolished. Finally, in 3 subjects, a dose-response curve was obtained, showing a steady but mild decrease in Gaw/Vgt (to a maximum of 10% loss) as doses of methoxamine were increased. These findings--(a) highly significant decrease in Gaw/Vgt after an inhaled {alpha} stimulant, (b) prevention of this by the concomitant inhalation of an {alpha} blocker, and (c) demonstration of a dose-related drug effect--suggest the presence of {alpha}-adrenergic receptors in the human tracheobronchial tree.

Submitted on January 18, 1971
Revised on June 10, 1971







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by the American Psychosomatic Society